K Lesli Ligorner

Employment

• Advising on pre-acquisition due diligence employment risks and liabilities and post-acquisition rectification strategies and risk mitigation for US-listed technology client in Guangdong Province, including social insurance underpayment, housing fund underpayment and non-enrollment, underpaid and incorrectly managed overtime, unlicensed dormitory and canteen, underage employees, shadow employees, unlawful labor dispatch practices and immigration irregularities
• Advising clients on strategic employment and compensation structures to meet regulatory requirements, achieve compensation goals and minimize permanent establishment risks
• Advising global investment banks on unionization and collective bargaining strategies in China
• Advising a global technology client with respect to post-termination restrictive covenants across 13 jurisdictions in APAC
• Advising on employment risks related to nonrenewal of US-listed telecommunications manufacturing client’s contract with outsourced equipment manufacturer while seeking to retain the employees for newly commencing contract in same location
• Preparing strategy for handling factory-wide claims of unpaid social benefits, underpaid overtime and other employment-related noncompliance in connection with significant restructuring exercise, resulting in no work disruptions
• Supervising the liquidation of a financial services company’s subsidiaries in Tianjin, Beijing and Shanghai and coordinating termination plan and documentation
• Preparing and conducting workplace training for China workforce regarding working hours and overtime issues, performance management, and general respect in the workplace
• Advising US-listed technology company on termination strategy and documentation for dismissal of multiple senior executives due to violations of company’s revenue recognition, channel management and anti-bribery policies
• Reviewing evidence from FCPA investigation and preparing strategy and coordinating disciplinary actions for 30+ employees in Chinese subsidiary of technology client, resulting in resignation of key wrongdoers

Investigations

• Leading investigation for global medical device manufacturer into allegations of self-dealing, bribery and corruption at China subsidiary
• Conducting investigation into 35+ transactions by Chinese subsidiary of US-listed life sciences company involving sales of instruments to government agencies, involving third parties placed on Entity List during investigation
• Coordinating investigation into expense reimbursement fraud by country manager and his assistant for US-listed audio equipment manufacturer’s Philippine’s subsidiary and assisting with post-investigation employment proceedings
• Supervising internal investigation concurrent with managing regulator’s investigation of whistleblower’s allegations of alleged trademark infringement by sole distributor and sub-distributor for European company’s government infrastructure business in China
• Conducting investigation into bribery allegations around regulatory approvals by US-listed life sciences company’s personnel in China
• Leading investigation into manipulation of sales and revenue recognition practices by Japanese management at subsidiary of US-listed technology company
• Supervising an investigation for US-listed medical device manufacturer into allegations reported by Chinese regulator regarding alleged corruption with respect to lab approvals for new medical devices
• Leading US-driven regulatory investigation into Chinese technology company’s alleged failure to take employment actions that were stipulated and agreed with US government agency
• Supervising an investigation into manipulation of revenue recognition policy for US-listed medical device company’s subsidiary in Japan and ensuing disciplinary hearings for multiple employees
• Conducting an investigation into sexual harassment and bribery allegations against a senior executive at a US-listed biotechnology company’s subsidiary in China
• Leading a cross-border investigation into allegations of commercial bribery and trade secret theft in Germany for a listed Chinese technology company, which findings were reported to the public prosecutor
• Leading an investigation into corruption at a US-listed medical device manufacturer’s subsidiary in China and advising on employment aspects with respect to off-books wage payments, individual income tax exposure, policy rollout and training, and management of dawn raid

Results may vary depending on your particular facts and legal circumstances.